Gene Logic last week announced the launch of the next generation of its Genesis Enterprise System software, version 2.0. The application is expected to be available in the fourth quarter this year, the company said. Existing customers of BioExpress and ToxExpress will receive the upgraded product. Genesis 2.0 includes analytical and visualization tools; multiple synchronized viewers; and tools for interactive and iterative outlier detection and removal, as well as data comparability assessment for integrated data sets; and capabilities for seamless integration of expression data and sample annotations with Gene Logic data.
Toshiba last week introduced Genelyzer, a chip-based DNA detection and analysis technology. The system revolves around electrochemical processes developed by the company in DNA current detection methods. The chip is 45 cm wide, 50 cm deep and 23 cm tall and interconnects with a system that automates all procedures – DNA extraction, amplification, hybridization reactions, detection, and identification. The Tokyo-based company entered the field in 2001 with the introduction of a screening chip targeting the liver disease hepatitis C, to be sold in the Japanese market, based on SNP data applicable only to the relatively homogeneous Japanese population. The company said the system will be marketed outside Japan.
MWG Biotech introduced its Inflammatory Array, a microarray for the analysis of a set of genes involved in inflammation and developed by researchers in the laboratory of Michael Kracht at the Medical School of Hanover (MHH). The microarray contains probes for 136 genes designed by MWG and validated at the MHH. Data from the validation process will be made available to customers through the company’s knowledge management system. The array is targeted at the clinical research market. Pricing was not provided.